Abortion pill hearing erupts into fiery debate over gender and pregnancy

A recent US Senate hearing on abortion pills took an unexpected turn when a Republican senator pressed a medical expert on gender and pregnancy. The exchange unfolded during a January 14 session of the Health, Education, Labor, and Pensions (HELP) Committee, where Dr. Nisha Verma, an obstetrician and gynaecologist, testified on reproductive health issues. Questions about biological definitions soon overshadowed the original topic of medication abortion. Senator Josh Hawley directed a blunt question at Dr. Verma: ‘Can men get pregnant?’ The physician paused and did not provide a direct answer. Hawley then rephrased his query, asking specifically about ‘biological men’—but again, Dr. Verma avoided a clear response.

The senator criticised her replies, arguing they ‘undermine science and erode public trust’. His remarks echoed a broader debate, including Justice Ketanji Brown Jackson’s 2022 confirmation hearing, where she declined to define the term ‘woman’.

Meanwhile, Congressman Buddy Carter went further, calling for Dr. Verma’s medical licence to be revoked. Physicians for Reproductive Health, however, defended her testimony, accusing the committee of spreading misinformation.

The hearing came as the US Supreme Court weighs a separate case on gender policy in women’s sports, involving the participation of biological men in female competitions. The committee’s session shifted from abortion access to a clash over biological definitions. Dr. Verma’s testimony drew sharp criticism from Republicans, while supporters dismissed the line of questioning as politically motivated. The debate reflects ongoing disputes over gender, science, and policy in US institutions.